Trial intelligence / Profile preview

Steroids and Oxygen in Recent Onset NAION

NCT02439866Phase 3Unknown

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Feb 2014
Primary completion
Jul 2015
Modality
Orthosteric Ligands, Inhalation Devices
Countries
1
01

Overview

A Phase 3 trial of methylprednisolone injection, oxygen in non-arteritic anterior ischemic optic neuropathy (NAION), sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.

02

Drugs

methylprednisolone injectionoxygen
03

Conditions

non-arteritic anterior ischemic optic neuropathy (NAION)

Beyond the preview

Go deeper on NCT02439866.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02439866.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call